![]() ![]() ![]() Most people with MS initially have relapses, which are a worsening of symptoms or the appearance of new symptoms for several days up to a few months. Side effects may include heart damage and certain blood cancers. Mitoxantrone (Novantrone): A healthcare professional will administer this four times per year.Therapy with this drug may increase the risk of autoimmune conditions. Alemtuzumab (Lemtrada): A healthcare professional will administer this for 5 days in a row, followed by 3 days 1 year later.The drug may increase the risk of infections and cancer. The FDA has approved the therapy for primary progressive and relapsing forms of MS. Ocrelizumab ( Ocrevus): A healthcare professional will administer this every 6 months.Experts associate the use of the drug with an increased chance of progressive multifocal leukoencephalopathy, a potentially fatal brain infection. Natalizumab ( Tysabri): A healthcare professional will administer this once per month.In addition to oral and self-injected drugs, DMTs include medications that a person receives through an intravenous (IV) infusion.Ī healthcare professional administers these through a needle placed into a person’s vein. Increasing dose from 2-20 mg per day over 14 days, then 20 mg per day Pain in the back, abdomen, or extremitiesĠ.23 mg for 4 days, followed by 0.46 mg for 5–7 days, followed by 0.92 mg once per day 95 mg twice daily for 1 week, followed by 190 mg twice per dayġ20 mg twice daily for 1 week, followed by a 240-mg capsule twice per dayĢ31 mg twice daily for 1 week, followed by 2 231-mg pills twice per dayĪ 0.5-mg capsule once per day for those weighing more than 40 kilograms (kg)Ġ.25 mg for those who weigh 40 kg or less
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |